Asklepios Group Reports Steady Growth in 2024

Hamburg-based Asklepios Kliniken GmbH & Co. KGaA announced stable growth in the first nine months of 2024. Revenues reached EUR 4,350.8 million, an increase from EUR 4,077.7 million the previous year. Patient numbers rose by 6%, totaling 2.7 million, underlining growing trust in their medical services.

Moreover, the group employed new refinancing strategies, doubling the issuing volume from EUR 250.0 million to EUR 500.0 million through the Social Finance Framework. This approach aligns with integrating sustainability into their financial strategy and maintaining flexibility amid market changes.

Asklepios Group remains confident about their strategic goals for the remainder of 2024, supported by synergies within the MEDICLIN and RHÖN networks. The company reports 50,398 full-time employees, slightly up from last year.